MarketCap
Facebook
X
Telegram
CTI BioPharma Corp. Operating Cycle | CTIC
Annual Operating Cycle CTI BioPharma Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90.1 | - | - | - | 114 | 1.19 K | 417 | 561 | 1.71 K | 13.5 K | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.5 K | 90.1 | 2.52 K |
Quarterly Operating Cycle CTI BioPharma Corp.
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 129 | - | 120 | 79.2 | 65 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 43.8 | 0.02 | 18.2 | 779 | 644 | 23.1 | 3.78 | 7.78 | 4.69 | 0.83 | 2.27 | 26.7 | 23.4 | 38.4 | 10.3 | 4.64 | 137 | 72.6 | 0.65 | 59.2 | 70.1 | 9.52 | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 779 | 0.02 | 91.3 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Wave Life Sciences Ltd.
WVE
|
11.5 | $ 3.42 | -0.15 % | $ 577 M |  Singapore |
 |
Exicure
XCUR
|
-4.16 | $ 1.05 | -2.78 % | $ 6.61 M |  USA |
 |
Xeris Pharmaceuticals
XERS
|
558 | $ 16.51 | 4.3 % | $ 2.65 B | USA |
 |
Molecular Templates
MTEM
|
4.53 | - | -23.43 % | $ 495 K | USA |
 |
22nd Century Group
XXII
|
169 | $ 1.57 | 10.56 % | $ 289 K | USA |
 |
Zai Lab Limited
ZLAB
|
186 | $ 26.42 | -0.04 % | $ 28.9 B |  China |
 |
Zoetis
ZTS
|
380 | $ 82.56 | 0.12 % | $ 36.6 B | USA |
 |
BioXcel Therapeutics
BTAI
|
1.66 K | $ 0.07 | 9.81 % | $ 855 K | USA |
 |
Navidea Biopharmaceuticals
NAVB
|
54.7 K | - | -2.99 % | $ 2.47 M | USA |
 |
BioDelivery Sciences International
BDSI
|
436 | - | -4.8 % | $ 255 M | USA |
 |
Insmed Incorporated
INSM
|
400 | $ 120.63 | 0.95 % | $ 24 B | USA |
 |
Novan
NOVN
|
234 | - | -24.84 % | $ 2.64 M | USA |
 |
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | USA |
 |
bluebird bio
BLUE
|
180 | - | - | $ 546 M | USA |
 |
Intra-Cellular Therapies
ITCI
|
257 | - | - | $ 13.6 B | USA |
 |
Marinus Pharmaceuticals
MRNS
|
59.8 | - | - | $ 29.6 M | USA |
 |
NeuBase Therapeutics
NBSE
|
-65.8 | - | -1.56 % | $ 12.3 M | USA |
 |
CASI Pharmaceuticals
CASI
|
189 | - | - | $ 35.4 M | USA |
 |
Sigilon Therapeutics
SGTX
|
31.4 | - | - | $ 728 M | USA |
 |
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | USA |
 |
Revance Therapeutics
RVNC
|
30.4 | - | - | $ 309 M | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
492 | $ 4.86 | 1.04 % | $ 787 M | USA |
 |
Epizyme
EPZM
|
47.2 | - | - | $ 249 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
8.16 K | - | -6.81 % | $ 3.04 B | USA |
 |
Nabriva Therapeutics plc
NBRV
|
214 | - | - | $ 4.55 M |  Irlanda |
 |
NGM Biopharmaceuticals
NGM
|
18.4 | - | - | $ 127 M | USA |
 |
9 Meters Biopharma
NMTR
|
111 | - | -42.97 % | $ 1.05 M | USA |
 |
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | USA |
 |
Theratechnologies
THTX
|
456 | - | - | $ 83.9 M |  Canada |
 |
Titan Pharmaceuticals
TTNP
|
81.3 | - | -3.76 % | $ 3.47 M | USA |